ARTICLE | Company News
Modulation Therapeutics, Multiple Myeloma Research Foundation (MMRF) cancer news
June 18, 2012 7:00 AM UTC
Modulation Therapeutics received a $500,000 grant from the foundation's Biotech Investment Award program to develop MTI-101 to treat multiple myeloma (MM). The CD44 inhibitor is in preclinical devel...